About 45% of executives at health care provider organizations, payers, and life science companies anticipate that the move to value-based reimbursement contracts would reduce profits for their organizations. Among health care provider organization executives, about 52% anticipate that value-based contracts will cause their operating income to drop. About 25% believe value-based contracts will result in a modest drop (less than 10%) to their operating income, 21% anticipate a drop of 10% to 50%, and 6% anticipate a drop of more than 50%. About a quarter anticipate a neutral impact on their operating results, and just under a . . .